![Hardman & Co](https://directorstalk.net/wp-content/uploads/2018/10/hardman-Co.png)
Tissue Regenix Group: Profitable and Cash-Generating Growth Strategy 2024
Tissue Regenix Group PLC (LON:TRX) is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a